Trademark: 86605899
Word
MEDIGENE IMMUNOTHERAPIES
Status
Dead
Status Code
710
Status Date
Friday, March 24, 2023
Serial Number
86605899
Registration Number
5038910
Registration Date
Tuesday, September 13, 2016
Mark Type
4000
Filing Date
Wednesday, April 22, 2015
Published for Opposition
Tuesday, June 28, 2016
Cancellation Date
Friday, March 24, 2023

Trademark Owner History
Medigene Immunotherapies GmbH - Original Registrant

Classifications
5 Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays for testing of bodily fluids for use in disease detection, namely, tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, all prepared by means of molecular biology, genetic engineering or biotechnological methods; substances for medical diagnosis purposes, namely, proteins, nucleic acids, cell products, protein conjugates, peptides, enzymes and enzyme preparations, particularly antibodies and T cell proteins; T cells, dendritic cells, and other cells of the immune system, viruses, and virus-like particles, all for medical purposes; liposomes for medical purposes; plant extracts for medical purposes; low molecular active ingredients, namely, medicines for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, adjuvants, serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical reagents and assays that test for the presence of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, autoimmune diseases and immune therapy
45 Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine
44 Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy
42 Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine
MEDIGENE IMMUNO THERAPIES
"IMMUNOTHERAPIES"

Trademark Events
Mar 24, 2023
Cancelled Sec. 8 (6-Yr)
Sep 13, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 13, 2016
Registered-Principal Register
Jun 28, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2016
Published For Opposition
Jun 8, 2016
Notification Of Notice Of Publication E-Mailed
May 23, 2016
Law Office Publication Review Completed
May 13, 2016
Approved For Pub - Principal Register
May 12, 2016
Teas/Email Correspondence Entered
May 12, 2016
Correspondence Received In Law Office
May 6, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
May 6, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2016
Teas Response To Office Action Received
Dec 17, 2015
Assigned To Examiner
Nov 9, 2015
Notification Of Non-Final Action E-Mailed
Nov 9, 2015
Non-Final Action E-Mailed
Nov 9, 2015
Non-Final Action Written
Oct 21, 2015
Teas/Email Correspondence Entered
Oct 21, 2015
Correspondence Received In Law Office
Oct 14, 2015
Assigned To Lie
Sep 23, 2015
Teas Response To Suspension Inquiry Received
Aug 7, 2015
Notification Of Letter Of Suspension E-Mailed
Aug 7, 2015
Letter Of Suspension E-Mailed
Aug 7, 2015
Suspension Letter Written
Aug 7, 2015
Examiner's Amendment Entered
Aug 7, 2015
Notification Of Examiners Amendment E-Mailed
Aug 7, 2015
Examiners Amendment E-Mailed
Aug 7, 2015
Examiners Amendment -Written
Jul 31, 2015
Assigned To Examiner
May 2, 2015
Notice Of Pseudo Mark E-Mailed
May 1, 2015
New Application Office Supplied Data Entered
Apr 25, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24